Shopping Cart
- Remove All
Your shopping cart is currently empty
Eudebeiolide B, isolated from Salvia plebeia R. Br., impedes osteoclastogenesis by modulating RANKL-induced NF-κB, c-Fos, and calcium signaling pathways, and is applicable in the study of osteoclast-related diseases [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
| Description | Eudebeiolide B, isolated from Salvia plebeia R. Br., impedes osteoclastogenesis by modulating RANKL-induced NF-κB, c-Fos, and calcium signaling pathways, and is applicable in the study of osteoclast-related diseases [1]. |
| In vitro | Eudebeiolide B (1-30 μΜ, 1 hour) inhibits RANKL-induced cellular differentiation in murine bone marrow-derived macrophages, suppressing the expression of osteoclastogenesis-related marker genes and RANKL-mediated cell signaling [1]. |
| In vivo | Eudebeiolide B (5 or 10 mg/kg, administered orally once a day for 6 weeks) prevented bone loss in an ovariectomized (OVX) mouse model caused by bilateral ovariectomy (OVX) [1]. |
| Synonyms | Plebeiolide D |
| Molecular Weight | 262.3 |
| Formula | C15H18O4 |
| Cas No. | 1934299-51-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.